173 related articles for article (PubMed ID: 21106178)
1. [Multi-drug resistant Pseudomonas aeruginosa: towards a therapeutic dead end?].
Barbier F; Wolff M
Med Sci (Paris); 2010 Nov; 26(11):960-8. PubMed ID: 21106178
[TBL] [Abstract][Full Text] [Related]
2. Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options.
Obritsch MD; Fish DN; MacLaren R; Jung R
Pharmacotherapy; 2005 Oct; 25(10):1353-64. PubMed ID: 16185180
[TBL] [Abstract][Full Text] [Related]
3. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa.
Rossolini GM; Mantengoli E
Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():17-32. PubMed ID: 15953020
[TBL] [Abstract][Full Text] [Related]
4. Emergence of highly antibiotic-resistant Pseudomonas aeruginosa in relation to duration of empirical antipseudomonal antibiotic treatment.
Philippe E; Weiss M; Shultz JM; Yeomans F; Ehrenkranz NJ
Clin Perform Qual Health Care; 1999; 7(2):83-7. PubMed ID: 10747571
[TBL] [Abstract][Full Text] [Related]
5. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
6. Current therapies for pseudomonas aeruginosa.
Giamarellou H; Kanellakopoulou K
Crit Care Clin; 2008 Apr; 24(2):261-78, viii. PubMed ID: 18361945
[TBL] [Abstract][Full Text] [Related]
7. Multi-drug resistant Pseudomonas aeruginosa and Acinetobacter baumannii infections among hospitalized patients: risk factors and outcomes.
Shanthi M; Sekar U
J Assoc Physicians India; 2009 Sep; 57():636, 638-40, 645. PubMed ID: 20214000
[TBL] [Abstract][Full Text] [Related]
8. Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa.
Yakupogullari Y; Otlu B; Dogukan M; Gursoy C; Korkmaz E; Kizirgil A; Ozden M; Durmaz R
Am J Infect Control; 2008 Dec; 36(10):e13-8. PubMed ID: 19084158
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium.
Mesaros N; Nordmann P; Plésiat P; Roussel-Delvallez M; Van Eldere J; Glupczynski Y; Van Laethem Y; Jacobs F; Lebecque P; Malfroot A; Tulkens PM; Van Bambeke F
Clin Microbiol Infect; 2007 Jun; 13(6):560-78. PubMed ID: 17266725
[TBL] [Abstract][Full Text] [Related]
10. [Hospital infections caused by Pseudomonas aeruginosa. Significance in intensive therapy].
Sidorenko SV; Gel'fand EB; Mamontova OA
Anesteziol Reanimatol; 1999; (3):46-54. PubMed ID: 10458038
[TBL] [Abstract][Full Text] [Related]
11. Efflux pump contribution to multidrug resistance in clinical isolates of Pseudomonas aeruginosa.
Kiser TH; Obritsch MD; Jung R; MacLaren R; Fish DN
Pharmacotherapy; 2010 Jul; 30(7):632-8. PubMed ID: 20575627
[TBL] [Abstract][Full Text] [Related]
12. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic susceptibility patterns of Pseudomonas aeruginosa to available antipseudomonal drugs in Ibadan, Nigeria.
Ogbolu DO; Ogunledun A; Adebiyi OE; Daini OA; Alli AO
Afr J Med Med Sci; 2008 Dec; 37(4):339-44. PubMed ID: 19301711
[TBL] [Abstract][Full Text] [Related]
14. [Antibiotic resistance of some Pseudomonas aeruginosa isolates].
Matinca D; Vancea D; Boboş C; Serban O
Bacteriol Virusol Parazitol Epidemiol; 2003; 48(2-3):157-61. PubMed ID: 15341333
[No Abstract] [Full Text] [Related]
15. Fluoroquinolone resistance of Pseudomonas aeruginosa isolates causing nosocomial infection is correlated with levofloxacin but not ciprofloxacin use.
Lee YJ; Liu HY; Lin YC; Sun KL; Chun CL; Hsueh PR
Int J Antimicrob Agents; 2010 Mar; 35(3):261-4. PubMed ID: 20045290
[TBL] [Abstract][Full Text] [Related]
16. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y
Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
[TBL] [Abstract][Full Text] [Related]
17. [Pseudomonas aeruginosa--a significant hospital pathogen and resistance to carbapenem].
Kucisec-Tepes N
Acta Med Croatica; 2004; 58(4):313-21. PubMed ID: 15700688
[TBL] [Abstract][Full Text] [Related]
18. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
[TBL] [Abstract][Full Text] [Related]
19. Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital.
Jung R; Fish DN; Obritsch MD; MacLaren R
J Hosp Infect; 2004 Jun; 57(2):105-11. PubMed ID: 15183239
[TBL] [Abstract][Full Text] [Related]
20. The evolution of Pseudomonas aeruginosa during antibiotic rotation in a medical intensive care unit: the RADAR-trial.
Tsukayama DT; van Loon HJ; Cartwright C; Chmielewski B; Fluit AC; van der Werken C; Verhoef J;
Int J Antimicrob Agents; 2004 Oct; 24(4):339-45. PubMed ID: 15380258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]